TrialAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Donanemab in preclinical Alzheimer's disease: Screening and baseline data from TRAILBLAZER-ALZ 3.

Roy Yaari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.